ERBB2 and breast carcinoma: High-quality, prospective controlled studies are needed to further clarify the relationship between HER2 protein expression level and the efficacy of various targeted therapies and in the future, treatment strategies can be adjusted individually according to HER2 expression level to improve the precision of breast cancer treatment.